AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16085658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bug Buster kit
Number of subjects: 133
Study 16085658 — intervention group
Group type: COMPARATOR
Intervention: Over the counter pediculicides
Number of subjects: 133
Study 12585711 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone replacement therapy
Number of subjects: 5
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers
Number of subjects: 78
Study 10613000 — intervention group
Group type: COMPARATOR
Intervention: Indian reviewers
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (non-exchanged group)
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (exchanged group)
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (exchanged)
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Indian reviewers (exchanged)
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall assessment by editors
Number of subjects: 78
Study 10613000 — intervention group
Group type: EXPERIMENTAL
Intervention: Time taken to return reviews
Number of subjects: 78
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal history of diabetes
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal history of diabetes
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use > 30 g/day
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake (total protein, animal protein, polyunsaturated fatty acids)
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use ≤ 30 g/day
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake
Number of subjects: 2484
Study 8612442 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 2484
Study 2184513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg daily)
Number of subjects: 37
Study 2184513 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole (400 mg daily)
Number of subjects: 37
Study 7033353 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (4 grams in four divided doses each day)
Number of subjects: 112
Study 7033353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg three times a day, 400 mg at night)
Number of subjects: 112
Study 7033353 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (control group)
Number of subjects: 112
Study 31498141 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation (CACR) using the ERICA platform
Number of subjects: 60
Study 31498141 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive training (SCT)
Number of subjects: 60
Study 28337719 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence intervention to nebulised and inhaled antibiotics
Number of subjects: 2979
Study 25889280 — intervention group
Group type: EXPERIMENTAL
Intervention: Food neophobia (measured using the Child Food Neophobia Scale)
Number of subjects: 330
Study 25889280 — intervention group
Group type: COMPARATOR
Intervention: Control group (NOURISH RCT)
Number of subjects: 330
Study 23712193 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin bonded bridgework (test group, n=40 patients)
Number of subjects: 82
Study 23712193 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=42 patients)
Number of subjects: 82
Study 21849024 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) program
Number of subjects: 200
Study 21849024 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 200
Study 19215005 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation by cardiology attendings
Number of subjects: 100
Study 19215005 — intervention group
Group type: COMPARATOR
Intervention: Auscultation by cardiology fellows, residents, and interns
Number of subjects: 100
Study 19215005 — intervention group
Group type: COMPARATOR
Intervention: Acoustic cardiography
Number of subjects: 100
Study 15847961 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexican ethnic group
Number of subjects: 0
Study 15847961 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerto Rican ethnic group
Number of subjects: 0
Study 15847961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuban and Dominican ethnic groups
Number of subjects: 0
Study 15847961 — intervention group
Group type: EXPERIMENTAL
Intervention: Social determinants of health
Number of subjects: 0
Study 12211217 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat with selected concomitant medications (amitriptyline, atorvastatin, cyclosporine, losartan, metformin, phentermine, and sibutramine)
Number of subjects: 0
Study 12211217 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective concomitant medications and orlistat
Number of subjects: 0
Study 12211217 — intervention group
Group type: COMPARATOR
Intervention: Selective concomitant medications alone
Number of subjects: 0
Study 10573044 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide treatment (20 mg/d)
Number of subjects: 482
Study 10573044 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate treatment (7.5-15 mg/wk)
Number of subjects: 482
Study 10573044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (carboplatin, etoposide, and bleomycin)
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified chemotherapy (carboplatin, etoposide, bleomycin, and cyclophosphamide)
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy only (without irradiation)
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Germinomas
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nongerminomatous GCT (NGGCT)
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival without relapse or progression
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor recurrence or progression
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful salvage therapy
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival probability
Number of subjects: 71
Study 8918487 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicity associated with study chemotherapy
Number of subjects: 71
Study 2021382 — intervention group
Group type: EXPERIMENTAL
Intervention: Unannounced sudden increase of the pain stimulus during the working-up procedure
Number of subjects: 0
Study 2021382 — intervention group
Group type: COMPARATOR
Intervention: Predictable pattern of pain stimuli
Number of subjects: 0
Study 6284334 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta-9-THC
Number of subjects: 214
Study 6284334 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine (Compazine)
Number of subjects: 214
Study 30929283 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion meditation (CM)
Number of subjects: 28
Study 30929283 — intervention group
Group type: COMPARATOR
Intervention: Veteran.calm (VC)
Number of subjects: 28
Study 28323444 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermeasures (6 types varying by type and modality)
Number of subjects: 72
Study 28323444 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistage alerts
Number of subjects: 72
Study 28323444 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory‐visual coffee cup icon
Number of subjects: 72
Study 28323444 — intervention group
Group type: COMPARATOR
Intervention: No countermeasure (baseline comparison)
Number of subjects: 72
Study 25908486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone implant
Number of subjects: 40
Study 24174657 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid hormone (TH) treatment
Number of subjects: 0
Study 24174657 — intervention group
Group type: COMPARATOR
Intervention: Control group (without IVH)
Number of subjects: 0
Study 20602123 — intervention group
Group type: EXPERIMENTAL
Intervention: Customised orthotic insoles (treatment group, n = 73)
Number of subjects: 228
Study 20602123 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control group, n = 147)
Number of subjects: 228
Study 18853141 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 113
Study 18853141 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 113
Study 17372175 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of isosorbide dinitrate and hydralazine hydrochloride (FDC I/H)
Number of subjects: 1050
Study 16099137 — intervention group
Group type: EXPERIMENTAL
Intervention: Word Completion Memory Test (WCMT)
Number of subjects: 71
Study 16099137 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological functioning tests and simulation tests
Number of subjects: 71
Study 16099137 — intervention group
Group type: EXPERIMENTAL
Intervention: WCMT and two additional simulation measures
Number of subjects: 71
Study 12373658 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study 10349954 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing heat and moisture exchangers every 48 hours
Number of subjects: 0
Study 10349954 — intervention group
Group type: COMPARATOR
Intervention: Changing heat and moisture exchangers every 24 hours
Number of subjects: 0
Study 7853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Abecarnil (10, 20, 40 mg)
Number of subjects: 14
Study 7853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (1.0, 2.0, 4.0 mg)
Number of subjects: 14
Study 7853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (high dose)
Number of subjects: 14
Study 7853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Abecarnil (high dose)
Number of subjects: 14
Study 7853170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2014889 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with diamorphine 0.0025%
Number of subjects: 61
Study 2014889 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with fentanyl 0.0002%
Number of subjects: 61
Study 2014889 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.125%
Number of subjects: 61
Study 7080851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular haloperidol decanoate injections (20 times and thereafter 15 times the optimal oral haloperidol dose)
Number of subjects: 11
Study 7080851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular haloperidol decanoate injections
Number of subjects: 11
Study 30052475 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 24
Study 30052475 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 24
Study 29845329 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab (T), 5-FU (F)/capecitabine (X), and cisplatin (P)
Number of subjects: 155
Study 26410538 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month behavioral lifestyle intervention
Number of subjects: 143
Study 26410538 — intervention group
Group type: COMPARATOR
Intervention: Usual presurgical care
Number of subjects: 143
Study 24701585 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal anesthesia with levobupivacaine (Group S)
Number of subjects: 60
Study 24701585 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (Group I)
Number of subjects: 60
Study 24701585 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol (Group T)
Number of subjects: 60
Study 22240407 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (30 mg/kg oral dose)
Number of subjects: 250
Study 22240407 — intervention group
Group type: COMPARATOR
Intervention: Benzathine benzylpenicillin (50,000 units/kg intramuscular injection)
Number of subjects: 250
Study 22240407 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 250
Study 22240407 — intervention group
Group type: COMPARATOR
Intervention: Benzathine benzylpenicillin
Number of subjects: 250
Study 20404280 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 162
Study 20404280 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 162
Study 17959952 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (continuous infusion of 5-15 microg x kg(‐1) x min(‐1))
Number of subjects: 90
Study 17959952 — intervention group
Group type: COMPARATOR
Intervention: Control (intermittent doses of fentanyl)
Number of subjects: 90
Study 17959952 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (continuous infusion of 0.1-0.5 microg x kg(‐1) x min(‐1))
Number of subjects: 90
Study 17959952 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (continuous infusion)
Number of subjects: 90
Study 15886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment
Number of subjects: 451
Study 15886232 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin treatment
Number of subjects: 451
Study 15886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurvivors
Number of subjects: 451
Study 15886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors
Number of subjects: 451
Study 15886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmortem liver D1 activity
Number of subjects: 451
Study 15886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmortem skeletal muscle D3 activity
Number of subjects: 451
Study 14727969 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy combined with early use of tirofiban and standard medical therapy
Number of subjects: 0
Study 14727969 — intervention group
Group type: COMPARATOR
Intervention: Standard therapeutic management options
Number of subjects: 0
Study 9521971 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Penile Nerve Block (DPNB)
Number of subjects: 50
Study 9521971 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream (0.5 g topically 1 hour before circumcision)
Number of subjects: 50
Study 9521971 — intervention group
Group type: COMPARATOR
Intervention: Circumcision without anesthesia (20 term newborns)
Number of subjects: 50
Study 9521971 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 50
Study 7619356 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg/day moexipril
Number of subjects: 108
Study 7619356 — intervention group
Group type: COMPARATOR
Intervention: 180 mg/day verapamil-SR
Number of subjects: 108
Study 2229460 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 99
Study 2229460 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 99
Study 2229460 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 99
Study 2229460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 897627 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme haemodilution with autologous transfusion
Number of subjects: 60
Study 897627 — intervention group
Group type: COMPARATOR
Intervention: Moderate haemodilution
Number of subjects: 60
Study 31597530 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 110
Study 31597530 — intervention group
Group type: COMPARATOR
Intervention: Bipolar electrocautery
Number of subjects: 110
Study 31597530 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study 31799616 — intervention group
Group type: EXPERIMENTAL
Intervention: Multielectrode tDCS of the left DLPFC
Number of subjects: 25
Study 31799616 — intervention group
Group type: EXPERIMENTAL
Intervention: Multielectrode tDCS of the right DLPFC
Number of subjects: 25
Study 31799616 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 25
Study 30170468 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam premedication
Number of subjects: 128
Study 27108826 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthetic trainee doctors
Number of subjects: 85
Study 27108826 — intervention group
Group type: COMPARATOR
Intervention: Nursing anaesthetic assistants
Number of subjects: 85
Study 24711842 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 40
Study 24711842 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 40
Study 22858124 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day lutein
Number of subjects: 108
Study 22858124 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day lutein
Number of subjects: 108
Study 22858124 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day lutein plus 10 mg/day zeaxanthin
Number of subjects: 108
Study 22858124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 21091279 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC‐TDF (emtricitabine and tenofovir disoproxil fumarate)
Number of subjects: 2499
Study 21091279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2499
Study 18717569 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice blend (JB), MonaVie Active
Number of subjects: 12
Study 18717569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15650890 — intervention group
Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 50
Study 12705112 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 239
Study 12705112 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 239
Study 12705112 — intervention group
Group type: COMPARATOR
Intervention: Inactive women without HRT
Number of subjects: 239
Study 10588987 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA‐BDP (QVAR)
Number of subjects: 31
Study 10588987 — intervention group
Group type: COMPARATOR
Intervention: CFC‐BDP (Beclovent)
Number of subjects: 31
Study 8762730 — intervention group
Group type: EXPERIMENTAL
Intervention: dexfenfluramine (d-FF) 15 mg twice daily for 6 days
Number of subjects: 15
Study 8762730 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 1915397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone plus aztreonam every 4 hours
Number of subjects: 478
Study 1915397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone plus aztreonam every 8 hours
Number of subjects: 478
Study 1915397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone plus aztreonam
Number of subjects: 478
Study 7038148 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate pre‐transplant blood transfusions
Number of subjects: 0
Study 7038148 — intervention group
Group type: COMPARATOR
Intervention: Random transfusions
Number of subjects: 0
Study 7038148 — intervention group
Group type: COMPARATOR
Intervention: No transfusions
Number of subjects: 0
Study 31972610 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich high-fiber diet
Number of subjects: 164
Study 31972610 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich high-fiber diet
Number of subjects: 164
Study 31972610 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsaturated fat-rich high-fiber diet
Number of subjects: 164
Study 30323234 — intervention group
Group type: EXPERIMENTAL
Intervention: New administration route (NEW.AR) of alprostadil cream
Number of subjects: 71
Study 30323234 — intervention group
Group type: COMPARATOR
Intervention: Standard administration route (ST.AR) of alprostadil cream
Number of subjects: 71
Study 29467437 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rTMS (n = 58): 63,000 high frequency rTMS pulses delivered as 3 treatments per day over 3 days in week 1, 3 treatments over 2 days in week 2 and 3 treatments on a single day in week 3
Number of subjects: 115
Study 29467437 — intervention group
Group type: COMPARATOR
Intervention: Standard rTMS (n = 57): 63,000 total high frequency rTMS pulses delivered over 5 days per week for 4 weeks
Number of subjects: 115
Study 27414655 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD‐TDV (recombinant live attenuated tetravalent dengue vaccine)
Number of subjects: 18
Study 27414655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 27414655 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD‐TDV
Number of subjects: 18
Study 24633488 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) + carbohydrate (CHO)
Number of subjects: 20
Study 24633488 — intervention group
Group type: COMPARATOR
Intervention: Placebo CHO
Number of subjects: 20
Study 22846190 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum interferential current (IFC) therapy, 12 sessions over 4 weeks.
Number of subjects: 58
Study 22846190 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy, 12 sessions over 4 weeks.
Number of subjects: 58
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine hypnotics and Z-drugs (e.g., zolpidem, zopiclone, zaleplon)
Number of subjects: 57
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine hypnotics and Z-drugs
Number of subjects: 57
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine hypnotics and Z-drugs with alcohol co-administration
Number of subjects: 57
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated daily use of hypnotic drugs
Number of subjects: 57
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem and zopiclone
Number of subjects: 57
Study 20171127 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaleplon
Number of subjects: 57